Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 204

Similar articles for PubMed (Select 9554347)

1.

Erectile response to transurethral alprostadil, prazosin and alprostadil-prazosin combinations.

Peterson CA, Bennett AH, Hellstrom WJ, Kaiser FE, Morley JE, Nemo KJ, Padma-Nathan H, Place VA, Prendergast JJ, Tam PY, Tanagho EA, Todd LK, Varady JC, Gesundheit N.

J Urol. 1998 May;159(5):1523-7; discussion 1527-8.

PMID:
9554347
3.

A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil.

Hellstrom WJ, Bennett AH, Gesundheit N, Kaiser FE, Lue TF, Padma-Nathan H, Peterson CA, Tam PY, Todd LK, Varady JC, Place VA.

Urology. 1996 Dec;48(6):851-6.

PMID:
8973666
4.

Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group.

Padma-Nathan H, Hellstrom WJ, Kaiser FE, Labasky RF, Lue TF, Nolten WE, Norwood PC, Peterson CA, Shabsigh R, Tam PY, Place VA, Gesundheit N.

N Engl J Med. 1997 Jan 2;336(1):1-7.

5.
6.

Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. MUSE Study Group.

Williams G, Abbou CC, Amar ET, Desvaux P, Flam TA, Lycklama à Nijeholt GA, Lynch SF, Morgan RJ, Müller SC, Porst H, Pryor JP, Ryan P, Witzsch UK, Hall MM, Place VA, Spivack AP, Gesundheit N.

Br J Urol. 1998 Jun;81(6):889-94.

PMID:
9666777
7.
8.

Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy.

Costabile RA, Spevak M, Fishman IJ, Govier FE, Hellstrom WJ, Shabsigh R, Nemo KJ, Rapport JL, Tam PY, Weldon KL, Gesundheit N.

J Urol. 1998 Oct;160(4):1325-8.

PMID:
9751346
9.
10.

Multicenter study of the treatment of erectile dysfunction with transurethral alprostadil (MUSE) in Korea.

Kim SC, Ahn TY, Choi HK, Choi NG, Chung TG, Chung WS, Hwang TK, Hyun JS, Jung GW, Kim CI, Kim JJ, Kim SW, Lee CH, Lee KS, Lee WH, Min KS, Moon KH, Paic JS, Park KS, Park NC, Park YK, Seo JK, Seo KK, Shin JS, Yoon YR, Lee WC.

Int J Impot Res. 2000 Apr;12(2):97-101.

PMID:
11052635
11.
12.

Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction.

Kaplan SA, Reis RB, Kohn IJ, Shabsigh R, Te AE.

Urology. 1998 Nov;52(5):739-43.

PMID:
9801091
13.

The effect of transurethral alprostadil on the quality of life of men with erectile dysfunction, and their partners. MUSE Study Group.

Williams G, Abbou CC, Amar ET, Desvaux P, Flam TA, Lycklama à Nijeholt GA, Lynch SF, Morgan RJ, Müller SC, Porst H, Pryor JP, Ryan P, Witzsch UK, Hall MM, Place VA, Spivack AP, Todd LK, Gesundheit N.

Br J Urol. 1998 Dec;82(6):847-54.

PMID:
9883223
14.
16.

Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.

Fulgham PF, Cochran JS, Denman JL, Feagins BA, Gross MB, Kadesky KT, Kadesky MC, Clark AR, Roehrborn CG.

J Urol. 1998 Dec;160(6 Pt 1):2041-6.

PMID:
9817319
17.

Alprostadil sterile powder formulation for intracavernous treatment of erectile dysfunction.

Colli E, Calabrò A, Gentile V, Mirone V, Soli M.

Eur Urol. 1996;29(1):59-62.

PMID:
8821692
18.

Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men.

Heaton JP, Lording D, Liu SN, Litonjua AD, Guangwei L, Kim SC, Kim JJ, Zhi-Zhou S, Israr D, Niazi D, Rajatanavin R, Suyono S, Benard F, Casey R, Brock G, Belanger A.

Int J Impot Res. 2001 Dec;13(6):317-21.

PMID:
11918246
19.

Intracavernous injections: still the gold standard for treatment of erectile dysfunction in elderly men.

Richter S, Vardi Y, Ringel A, Shalev M, Nissenkorn I.

Int J Impot Res. 2001 Jun;13(3):172-5.

PMID:
11525316
20.

Optimizing the therapeutic approach of transurethral alprostadil.

Ekman P, Sjögren L, Englund G, Persson BE.

BJU Int. 2000 Jul;86(1):68-74.

PMID:
10886086
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk